-+ 0.00%
-+ 0.00%
-+ 0.00%

How Strong Q4 Results And Georgia Expansion At Concentra (CON) Has Changed Its Investment Story

Simply Wall St·02/19/2026 13:16:39
Listen to the news
  • Concentra Group Holdings Parent recently reported strong Q4 preliminary results and, despite broader macroeconomic volatility, continued its U.S. footprint expansion by opening a new occupational health medical center in Georgia.
  • This combination of resilient operating performance and ongoing clinic rollout underscores how Concentra is reinforcing access to employer-focused health services while steadily building its network.
  • We’ll now examine how Concentra’s resilient Q4 performance and Georgia clinic expansion may influence the company’s broader investment narrative.

Outshine the giants: these 25 early-stage AI stocks could fund your retirement.

Concentra Group Holdings Parent Investment Narrative Recap

To own Concentra, you generally need to believe that employer-focused occupational health remains a durable, cash generative niche and that management can translate clinic expansion into steady visit volumes while managing costs. The strong Q4 pre-announcement and Georgia opening reinforce the near term growth catalyst of network build out, but do not materially change the key risk that slower organic volume trends and higher costs could restrain earnings progress.

Against this backdrop, Concentra’s January 2026 guidance for US$2.25 billion to US$2.35 billion in full year revenue and US$182 million to US$197 million in net income is particularly relevant, as it frames how much headroom the company has to absorb integration and G&A pressures while expanding its clinic base. The latest Georgia clinic addition fits into that broader plan of measured footprint growth supported by already communicated financial targets.

However, while growth via new centers is appealing, investors should also be aware of...

Read the full narrative on Concentra Group Holdings Parent (it's free!)

Concentra Group Holdings Parent's narrative projects $2.6 billion revenue and $249.0 million earnings by 2028. This requires 8.4% yearly revenue growth and a $100.9 million earnings increase from $148.1 million.

Uncover how Concentra Group Holdings Parent's forecasts yield a $28.57 fair value, a 20% upside to its current price.

Exploring Other Perspectives

CON 1-Year Stock Price Chart
CON 1-Year Stock Price Chart

Two Simply Wall St Community fair value estimates for Concentra span roughly US$24.87 to US$28.57, underscoring how differently individual investors can price the same cash flows. Against that variety of views, the recent Q4 strength and clinic expansion sit alongside concerns about elevated G&A costs and leverage, which could influence how you weigh the company’s ability to convert its footprint into sustainable earnings.

Explore 2 other fair value estimates on Concentra Group Holdings Parent - why the stock might be worth as much as 20% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.